Weekly Scoop #85

✨ $100M Series D, FDA approval, and a new research institute
Author:
Molly Taylor
Published:
February 6, 2026

💰Midi Health reaches unicorn status after closing  $100M Series D and reaching $1B+ valuation

Midi Health, the virtual women’s health clinic focused on perimenopause and menopause care, raised $100 million in a Series D round, pushing its valuation past $1 billion as it scales nationwide and broadens services across life stages.

"Investors are backing us because we can demonstrate that there's an opportunity to build a national healthcare company. We can show that you can build a national healthcare company and scale access to really high-quality care, and there are lots and lots of women who need this care."Joanna Strober, Co-founder & CEO, Midi Health

🔗 https://www.fiercehealthcare.com/health-tech/womens-health-clinic-midi-health-closes-100m-series-d-round-hitting-1b-valuation

📈 Hologic receives FDA approval for Aptima HPV assay as a primary cervical cancer screening option

Hologic’s Aptima HPV Assay received FDA approval for clinician-collected HPV primary screening, expanding its cervical health portfolio and offering providers more flexibility alongside existing co-testing and Pap methods to help detect precancerous lesions and reduce cervical cancer risk.

"Pelvic floor physical therapy is the standardof care. We've shifted pelvic floortherapy from niche to norm. This new round of funding will enable us to move it from norm to non-negotiable." — Carine Carmy, Co-founder & CEO, Origin

🔗 https://investors.hologic.com/press-releases/press-release-details/2026/Hologic-Receives-FDA-Approval-for-Aptima-HPV-Assay-Primary-Screening-Option-Expanding-Cervical-Health-Portfolio/default.aspx?_hsenc=p2ANqtz-8hlQbIscx7dudQF8JUxYlgwfg2NIuQhcTNNXE3tafk4h7nj9I82KxU79TWECLzHE6-K0BjGx12nhbGW32f9JSe7wJS-A0zHUfvM8tAqHenDjKtxt4&_hsmi=2

📊 Maven Clinic launches digital health focused clinical research institute for digital health

Maven Clinic announced the launch of its Clinical Research Institute, a new arm aimed at rigorously evaluating the impact of digital health solutions on women’s and family-focused care, building on more than 40 peer-reviewed studies and positioning evidence generation at the heart of digital care adoption.

🔗 https://www.prnewswire.com/news-releases/maven-clinic-launches-clinical-research-institute-to-set-the-evidence-standard-for-digital-health-for-women-and-families-302673567.html?_hsenc=p2ANqtz-_yukAQxvORGNAvUDB7-nmffgTsY0I0-TRYDKDrzUX4MUqvfJWFN-PPRt80q1lI7-zabf-tEzSJaVsrZVzt_ekDYxcjxK2QV0qMBKXZxZFNTBtj76c&_hsmi=2

🚀 Organon launches third edition of women’s health accelerator program across EMEA

Organon has opened applications for the third edition of its Women’s Health Accelerator Program, now expanded to include the Middle East, Turkey and Africa (META). The initiative is designed to support early-stage digital health start-ups in family planning, fertility and women’s wellness with access to mentoring, workshops and investor networks through Feb 12, 2026.

"When a third of people are waiting over a week just to see their GP, it's time to think through alternative solutions that help people get the care they need while supporting NHS capacity. We're making healthcare as accessible as online banking, and this funding lets us prove that model works at scale." — Amit Kakar, Managing Partner & Head of Asia,  Novo Holdings

🔗 https://www.prnewswire.com/news-releases/organon-launches-third-edition-of-womens-health-accelerator-program-across-middle-east-turkey--africa-302678806.html?_hsenc=p2ANqtz-_252e_4z1wOMEUZx82GPjvuRdKaXtJXCnm00fnwratjN6Pt2QSxJrGD-TIAtGdiHfSGAxnm2qF-UvdWXDEZ8cjnTrzrX1chgBupe3D32vB4cDZ6-w&_hsmi=2